While China has confirmed that coronavirus cases are dropping outside Wuhan and Hubei province, the numbers are now spiking outside China. One of the leading antiviral hopes for the spreading outbreak, Gilead Sciences Inc.’s remdesivir, is now in a Phase III study in Wuhan after being used to treat the first confirmed patient in the US with promising results.
Surprisingly, the Wuhan study with the drug has encountered challenges including finding enough patients to enroll, noted a World Health...




![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)

